Economic and humanistic burden of fibromyalgia in the USA

References

• Klippel JH, Freundlich B, Leventhal L. Primer on rheumatic diseases. Arthritis Foundation11, 123–127 (1998).
   Google Scholar
• Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am. J. Med.92, 363–367 (1992).
   PubMed Web of Science ®Google Scholar
• Winfield JB. Pain in fibromyalgia. Rheum. Dis. Clin. North Am.25(1), 55–79 (1999).
   PubMed Web of Science ®Google Scholar
• Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain102, 243–250 (2003).
   PubMed Web of Science ®Google Scholar
• Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode presentation. Pain105, 403–413 (2003).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Norregaard J, Jensen R, Olesen J. Evidence of qualitatively altered nociception in patients with fibomyalgia. Arthritis Rheum.40(1), 98–102 (1997).
   PubMed Web of Science ®Google Scholar
• Friedberg F, Jason LA. Chronic fatigue syndrome and fibromyalgia: clinical assessment and treatment. J. Clin. Psychol.57(4), 433–455 (2001).
   PubMed Web of Science ®Google Scholar
• Burckhardt CS, Goldenberg D, Crofford L et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. APS Clinical Practice Guidelines Series, No. 4. American Pain Society, Glenview, IL, USA (2005).
   Google Scholar
• Wolfe F, Smythe H, Yunus M et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum.33(2), 160–172 (1990).
   PubMed Web of Science ®Google Scholar
• Goldenberg D, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA292(19), 2388–2395 (2004).
   PubMed Web of Science ®Google Scholar
• Lash AA, Ehrlich-Jones L, McCoy D. Fibromyalgia: evolving concepts and management in primary care settings. Medsurg. Nurs.12(3), 145–190 (2003).
   Google Scholar
• O’Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J. Gen. Intern. Med.15, 659–666 (2000).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics41(2), 104–113 (2000).
   PubMed Web of Science ®Google Scholar
• Dayer P, Collart L, Desmeules J. The pharmacology of tramadol. Drugs47(Suppl. 1), 3–7 (1994).
   PubMed Web of Science ®Google Scholar
• Gobbi M, Mennini T. Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser. Eur. J. Pharmacol.370, 23–26 (1999).
   Google Scholar
• Sagata K, Minami K, Yanagihara N et al. Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells. Anesth. Analg.94, 901–906 (2002).
   PubMed Web of Science ®Google Scholar
• Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. J. Am. Med. Assoc.280(21), 1831–1836 (1998).
   PubMed Web of Science ®Google Scholar
• Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med.159(16), 1931–1937 (1999).
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J. Am. Med. Assoc.280(21), 1837–1842 (1998).
   PubMed Web of Science ®Google Scholar
• Rossy LA, Buckelew SP, Hagglund KJ et al. A meta-analysis of fibromyalgia treatment interventions. Ann. Behav. Med.21, 18091 (1999).
   Google Scholar
• Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions in fibromyalgia. Clin. J. Pain18, 324–336 (2002).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Anderson J, Russell J, Herbert L. The prevalence of fibromyalgia in the general population. Arthritis Rheum.38, 19–28 (1995).
   PubMed Web of Science ®Google Scholar
• White K, Speechley M, Harth M, Ostbye T. The London Fibromyalgia epidemiology study: the prevalence of fibromyalgia in London Ontario. J. Rheumatol.26, 1570–1576 (1999).
   PubMed Web of Science ®Google Scholar
• Leslie A, Burke M, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and tempromandibular disorder. Arch. Intern. Med.16, 221–227 (2000).
   Google Scholar
• Wolfe F, Anderson J, Harkness D et al. A prospective, longitudinal, multicenter study of service utilization. Arthritis Rheum.40, 1560–1570 (1997).
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Dobkin P, Civita M, Penrod J. Comorbidity and physician use on fibromyalgia. Swiss Med. Wkly135, 76–81 (2005).
   PubMed Web of Science ®Google Scholar
• Greenberg P, Leong S, Birnbaum H, Robinson R. The economic burden of depression with painful symptoms. J. Clin. Psychiatry64(Suppl.), 17–23 (2003).
   PubMedGoogle Scholar
• Robinson R, Birnbaum H, Morley M, Sisitsky T, Greenberg P, Wolfe F. Depression and fibromyalgia: treatment and costs when diagnosed separately or concurrently. J. Rheumatol.31, 1621–1629 (2004).
   PubMed Web of Science ®Google Scholar
• Robinson R, Birnbaum H, Morley M, Sisitsky T, Greenberg P, Claxton A. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J. Rheumatol.30, 1318–1325 (2003).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J. Rheumatol.31, 695–700 (2004).
   PubMed Web of Science ®Google Scholar
• Whalen H, Cronan T, Bigatti S. Factors associated with healthcare costs in women with fibromyalgia. Am. J. Manag. Care7, SP39–SP47 (2001).
   Google Scholar
• Bigatti S, Cronana. An examination of the physical health, health care use, and psychological well-being of spouses of people with fibromyalgia syndrome. Health Psychol.21, 157–166 (2002).
   PubMed Web of Science ®Google Scholar
• Lightfoot R, Luft B, Rahn D et al. Empirical parental antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann. Intern. Med.119, 503–509 (1993).
   Google Scholar
• Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J. Rheumatol.20, 475–479 (1993).
   PubMed Web of Science ®Google Scholar
• Gaston-Johansson F, Gustafsson M, Felldin R, Sanne H. A comparative study of feelings, attitudes and behaviors of patients with fibromyalgia and rheumatoid arthritis. Soc. Sci. Med.31, 941–947 (1990).
   PubMed Web of Science ®Google Scholar
• Bernard A, Prince A, Edsall P. Quality of life issues for fibromyalgia patients. Arthritis Care Res.13(1), 42–50 (2000).
   PubMed Web of Science ®Google Scholar
• Reisine S, Fifiel J, Walsh SJ, Feinn R. Do employment and family work affect the health status of women with fibromyalgia. J. Rheumatol.30(9), 2045–2053 (2003).
   PubMed Web of Science ®Google Scholar
• Paulson M, Norberg A, Danielson E. Men living with fibromyalgia-type pain: experiences as patients in the swedish health care system. J. Adv. Nurs.40(1), 87–95 (2002).
   PubMed Web of Science ®Google Scholar
• Bernard AL, Prince A, Edsall P. Quality of life issues for fibromyalgia patients. Arthritis Care Res..13(1), 42–50 (2000).
   PubMed Web of Science ®Google Scholar
• Martinez JE, Berraz MB, Sato EI, Atra E. Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J. Rheumatol.22(2), 270–274 (1995).
   PubMed Web of Science ®Google Scholar
• Valim V, Oliveira L, Suda A et al. Aerobic fitness effects in fibromyalgia. J. Rheumatol.30(5), 1060–1069 (2003).
   PubMed Web of Science ®Google Scholar
• Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain68(2–3), 363–368 (1996).
   PubMed Web of Science ®Google Scholar
• Soderberg S, Lundman B, Norberg A. The meaning of fatigue and tiredness as narrated by women with fibromyalgia and healthy women. J. Clin. Nurs.11(2), 247–255 (2002).
   PubMed Web of Science ®Google Scholar
• Cudney SA, Butler MR, Weinert C, Sullivan T. Ten rural women living with fibromyalgia tell it like it is. Holist. Nurs. Pract.16(3), 35–45 (2002).
   PubMedGoogle Scholar
• Meenan R, Mason J, Anderson J et al. AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis Rheum.35, 1–10 (1992).
   PubMed Web of Science ®Google Scholar
• McConnell S, Kolopack P, Davis AM. The Western Ontario and McMAster Universities Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum.45(5), 453–461 (2001).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Kong SX. Rasch analysis of the Western Ontario MacMaster Questionnaire (WOMAC) in 2205 patietns with osteoarthritis, rheumatoid arthritis and fibromyalgia. Ann. Rheum. Dis.58(9), 563–568 (1999).
   PubMed Web of Science ®Google Scholar
• Bellany N, Buchanan WW, Goldsmith CH et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J. Rheumatol.15, 1833–1840 (1988).
   Google Scholar
• Wright JG, Young NL. A comparison of different indices of responsiveness. J. Clin. Epidemiol.50(3), 239–246 (1997).
   PubMed Web of Science ®Google Scholar
• Brazier JE, Harper R, Munro J et al. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology38(9), 870–877 (1999).
   PubMed Web of Science ®Google Scholar
• Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J. Rheumatol.18(5), 728–733 (1991).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Hawley DJ, Goldenberg DL, Russell J, Buskila D, Neumann L. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J. Rheumatol.27(8), 1989–1999 (2000).
   PubMed Web of Science ®Google Scholar
• Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG. Treatment with Staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome – a randomized controlled trial. Eur. J. Pain6(6), 455–466 (2002).
   PubMed Web of Science ®Google Scholar
• Ware JE, Sherbourne CD. The MOS 35-Item Short-Form Health Survey (SF-36). I. conceptual framework and item selection. Med. Care30(6), 473–483 (1992).
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Razcek AE. The MOS 36-Item Short-Form Health Survey (SF-36):II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care31(3), 427–463 (1993).
   Google Scholar
• McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III.Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care32(1), 40–66 (1994).
   PubMed Web of Science ®Google Scholar
• Dean BB, Aguilar D, Barghout V et al. Impairment in work productivity and health-related quality of life in patients with irritable bowel syndrome. Am. J. Manag. Care11, S17–S26 (2005).
   PubMed Web of Science ®Google Scholar